JXR Buys Back 7.30 Million Shares for HK$15.02 Million; Cumulative Repurchases Reach 119.59 Million Under 2025 Mandate

Bulletin Express
06/23

Jinxin Fertility Group Limited (“JXR”) disclosed a Next Day Return showing the on-market repurchase of 7.30 million ordinary shares on 23 June 2026.

• Transaction details – Volume: 7,303,500 shares – Price range: HK$2.03–HK$2.08 per share – Volume-weighted average price: HK$2.06 – Aggregate consideration: HK$15.02 million

• Outstanding buy-backs awaiting cancellation – Total shares repurchased but not yet cancelled between 27 March and 23 June 2026 amount to 79.92 million, equivalent to approximately 2.96 % of the company’s 2.71 billion issued shares. – The latest purchase will also be cancelled, leaving treasury shares at zero.

• Position under existing mandate – Shareholders granted a mandate on 26 June 2025 allowing the company to buy back up to 274.47 million shares. – After the latest transaction, 119.59 million shares have been repurchased, utilising 4.36 % of issued shares as at the mandate date. – A 30-day moratorium on new share issues or sales of treasury stock is in force until 23 July 2026.

• Capital structure – Issued share capital stands at 2.71 billion shares; no new shares have been issued over the period covered by the return.

All repurchases were executed on the Hong Kong Stock Exchange in accordance with Main Board Rule 10.06, and the company confirms no changes to the explanatory statement filed on 4 June 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10